The primary aim of this study was to assess the potential impact of the Thr92Ala and ORFa‐Gly3Asp variants in DIO2 gene on SCH susceptibility, with a focus on the interaction between these polymorphisms and thyroid hormone levels. Here, DIO2 is linked to spindle cell hemangioma.